{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,22]],"date-time":"2026-11-22T04:17:35Z","timestamp":1795321055418,"version":"4.10.3"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T00:00:00Z","timestamp":1639353600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To compare demographic and clinical characteristics of patients with axial SpA (axSpA) across geographic regions.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Patients With Axial Spondyloarthritis: Multicountry Registry of Clinical Characteristics (PROOF) is an observational study that enrolled recently diagnosed (\u22641\u2009year) axSpA patients fulfilling the Assessment of SpondyloArthritis international Society classification criteria from rheumatology clinical practices in 29 countries across six geographic regions. Demographics and disease-related parameters were collected. Here we present baseline data for patients who were classified as radiographic axSpA (r-axSpA) or non-radiographic axSpA (nr-axSpA) confirmed by central reading.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of the 2170 patients enrolled, 1553 were classified based on central evaluation of sacroiliac radiographs [r-axSpA: 1023 (66%); nr-axSpA: 530 (34%)]. Patients with nr-axSpA had a significantly higher occurrence of enthesitis (40% vs 33%), psoriasis (10% vs 5%) and IBD (4% vs 2%) vs r-axSpA patients. Significant differences in axSpA characteristics were observed between geographic regions. The highest occurrence of peripheral arthritis (60%), enthesitis (52%) and dactylitis (12%) was in Latin America, and the lowest was in Canada (9%, 9% and 2%, respectively). The occurrence of uveitis and psoriasis was highest in Canada (18% and 14%, respectively) and lowest in China (6% and &amp;lt;1%, respectively). IBD was highest in Arabia (21%), and no cases were observed in China. In multivariable analysis adjusted for factors potentially affecting peripheral and extramusculoskeletal manifestations, geographic regions still exhibited significant differences in frequencies of uveitis (P\u2009&amp;lt;\u20090.01), psoriasis (P\u2009&amp;lt;\u20090.0001) and peripheral arthritis (P\u2009&amp;lt;\u20090.0001).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The multinational PROOF study of axSpA patients showed significant regional differences in peripheral and extramusculoskeletal manifestations of SpA, which could be considered in management guidelines and clinical trials.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keab901","type":"journal-article","created":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T12:20:34Z","timestamp":1639138834000},"page":"3299-3308","source":"Crossref","is-referenced-by-count":53,"title":["Characteristics of patients with axial spondyloarthritis by geographic regions: PROOF multicountry observational study baseline results"],"prefix":"10.1093","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4537-6015","authenticated-orcid":false,"given":"Denis","family":"Poddubnyy","sequence":"first","affiliation":[{"name":"Division of Gastroenterology, Infectious Diseases and Rheumatology, Charit\u00e9-Universit\u00e4tsmedizin Berlin"},{"name":"Epidemiology Unit, German Rheumatism Research Centre , Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Sieper","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Infectious Diseases and Rheumatology, Charit\u00e9-Universit\u00e4tsmedizin Berlin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Servet","family":"Akar","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Rheumatology, Izmir Katip Celebi University , Izmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2758-2085","authenticated-orcid":false,"given":"Santiago","family":"Mu\u00f1oz-Fern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Servicio de Reumatolog\u00eda, Hospital Universitario Infanta Sof\u00eda, Universidad Europea , Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5180-1831","authenticated-orcid":false,"given":"Hildrun","family":"Haibel","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Infectious Diseases and Rheumatology, Charit\u00e9-Universit\u00e4tsmedizin Berlin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Hojnik","sequence":"additional","affiliation":[{"name":"Global Medical Affairs Rheumatology, AbbVie Inc. , Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana","family":"Ganz","sequence":"additional","affiliation":[{"name":"Global Medical Affairs, AbbVie Inc. , Baar, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D","family":"Inman","sequence":"additional","affiliation":[{"name":"Schroeder Arthritis Institute, University Health Network, University of Toronto , Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,12,13]]},"reference":[{"key":"2022080318254523000_keab901-B1","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.rdc.2012.08.002","article-title":"Classification, diagnosis, and referral of patients with axial spondyloarthritis","volume":"38","author":"Braun","year":"2012","journal-title":"Rheum Dis Clin North Am"},{"key":"2022080318254523000_keab901-B2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0140-6736(16)31591-4","article-title":"Axial spondyloarthritis","volume":"390","author":"Sieper","year":"2017","journal-title":"Lancet"},{"key":"2022080318254523000_keab901-B3","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00296-002-0237-4","article-title":"Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis","volume":"23","author":"Feldtkeller","year":"2003","journal-title":"Rheumatol Int"},{"key":"2022080318254523000_keab901-B4","first-page":"2283","article-title":"Delay to diagnosis in axial spondyloarthritis: are we improving in the UK?","volume":"54","author":"Sykes","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"2022080318254523000_keab901-B5","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1093\/rheumatology\/kez090","article-title":"Determinants of diagnostic delay in axial spondyloarthritis: an analysis based on linked claims and patient-reported survey data","volume":"58","author":"Redeker","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"2022080318254523000_keab901-B6","first-page":"263","article-title":"Incidence and prevalence of axial spondyloarthritis: methodologic challenges and gaps in the literature","volume":"36","author":"Bohn","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"2022080318254523000_keab901-B7","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1002\/acr.21688","article-title":"Do patients with non-radiographic axial spondylarthritis differ from patients with ankylosing spondylitis?","volume":"64","author":"Kiltz","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2022080318254523000_keab901-B8","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/rheumatology\/ken506","article-title":"First signs and symptoms of spondyloarthritis\u2014data from an inception cohort with a disease course of two years or less (REGISPONSER-Early)","volume":"48","author":"Rojas-Vargas","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"2022080318254523000_keab901-B9","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/1529-0131(199801)41:1<58::AID-ART8>3.0.CO;2-G","article-title":"Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors","volume":"41","author":"Braun","year":"1998","journal-title":"Arthritis Rheum"},{"key":"2022080318254523000_keab901-B10","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s13075-016-1093-z","article-title":"Prevalence of peripheral and extra-articular disease in ankylosing spondylitis versus non-radiographic axial spondyloarthritis: a meta-analysis","volume":"18","author":"de Winter","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"2022080318254523000_keab901-B11","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","article-title":"Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria","volume":"27","author":"van der Linden","year":"1984","journal-title":"Arthritis Rheum"},{"key":"2022080318254523000_keab901-B12","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1136\/ard.2009.108217","article-title":"The development of Assessment of SpondyloArthritis International Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"2022080318254523000_keab901-B13","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.semarthrit.2014.10.009","article-title":"The burden of non-radiographic axial spondyloarthritis","volume":"44","author":"Boonen","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"2022080318254523000_keab901-B14","doi-asserted-by":"crossref","first-page":"e000053","DOI":"10.1136\/rmdopen-2015-000053","article-title":"Non-radiographic axial spondyloarthritis and ankylosing spondylitis: what are the similarities and differences?","volume":"1","author":"Baraliakos","year":"2015","journal-title":"RMD Open"},{"key":"2022080318254523000_keab901-B15","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/art.24483","article-title":"The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis Inception Cohort","volume":"60","author":"Rudwaleit","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2022080318254523000_keab901-B16","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1186\/s13075-015-0897-6","article-title":"Comparison of non-radiographic axial spondyloarthritis and ankylosing spondylitis patients\u2014baseline characteristics, treatment adherence, and development of clinical variables during three years of anti-TNF therapy in clinical practice","volume":"17","author":"Wallman","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"2022080318254523000_keab901-B17","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1093\/rheumatology\/ket207","article-title":"Factors associated with radiographic lesions in early axial spondyloarthritis. Results from the DESIR cohort","volume":"52","author":"Blachier","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"2022080318254523000_keab901-B18","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1002\/art.38140","article-title":"Tumor necrosis factor \u03b1 inhibition in radiographic and nonradiographic axial spondyloarthritis: results from a large observational cohort","volume":"65","author":"Ciurea","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2022080318254523000_keab901-B19","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.3899\/jrheum.130588","article-title":"Ankylosing spondylitis and nonradiographic axial spondyloarthritis: part of a common spectrum or distinct diseases?","volume":"40","author":"Wallis","year":"2013","journal-title":"J Rheumatol"},{"key":"2022080318254523000_keab901-B20","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1093\/rheumatology\/ket164","article-title":"Percentage of patients with spondyloarthritis in patients referred because of chronic back pain and performance of classification criteria: experience from the Spondyloarthritis Caught Early (SPACE) cohort","volume":"52","author":"van den Berg","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"2022080318254523000_keab901-B21","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s00296-014-3168-y","article-title":"Discriminant validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with non-radiographic axial spondyloarthritis and ankylosing spondylitis: a cohort study","volume":"35","author":"Kilic","year":"2015","journal-title":"Rheumatol Int"},{"key":"2022080318254523000_keab901-B22","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1002\/art.39225","article-title":"Brief report: clinical course over two years in patients with early nonradiographic axial spondyloarthritis and patients with ankylosing spondylitis not treated with tumor necrosis factor blockers: results from the German Spondyloarthritis Inception Cohort","volume":"67","author":"Poddubnyy","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2022080318254523000_keab901-B23","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1136\/annrheumdis-2012-202389","article-title":"Similar response rates in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis after 1 year of treatment with etanercept: results from the ESTHER trial","volume":"72","author":"Song","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2022080318254523000_keab901-B24","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1136\/annrheumdis-2018-213184","article-title":"Ankylosing Spondylitis Disease Activity Score (ASDAS): 2018 update of the nomenclature for disease activity states","volume":"77","author":"Machado","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2022080318254523000_keab901-B25","doi-asserted-by":"crossref","first-page":"e001450","DOI":"10.1136\/rmdopen-2020-001450","article-title":"Prevalence and distribution of peripheral musculoskeletal manifestations in spondyloarthritis including psoriatic arthritis: results of the worldwide, cross-sectional ASAS-PerSpA study","volume":"7","author":"Lopez-Medina","year":"2021","journal-title":"RMD Open"},{"key":"2022080318254523000_keab901-B26","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1002\/art.40551","article-title":"Association of inflammatory bowel disease and acute anterior uveitis, but not psoriasis, with disease duration in patients with axial spondyloarthritis: results from two Belgian nationwide axial spondyloarthritis cohorts","volume":"70","author":"Varkas","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"2022080318254523000_keab901-B27","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1007\/s10067-017-3655-0","article-title":"Prevalence of HLA-B27 in the general population and in patients with axial spondyloarthritis in Saudi Arabia","volume":"36","author":"Omair","year":"2017","journal-title":"Clin Rheumatol"},{"key":"2022080318254523000_keab901-B28","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.3899\/jrheum.090625","article-title":"Undifferentiated spondyloarthritis: a longterm followup","volume":"37","author":"Sampaio-Barros","year":"2010","journal-title":"J Rheumatol"},{"key":"2022080318254523000_keab901-B29","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/014107680409700102","article-title":"The ramifications of HLA-B27","volume":"97","author":"Sheehan","year":"2004","journal-title":"J R Soc Med"},{"key":"2022080318254523000_keab901-B30","doi-asserted-by":"crossref","first-page":"1179544117751627","DOI":"10.1177\/1179544117751627","article-title":"Does HLA-B27 status influence ankylosing spondylitis phenotype?","volume":"11","author":"Akassou","year":"2018","journal-title":"Clin Med Insights Arthritis Musculoskelet Disord"},{"key":"2022080318254523000_keab901-B31","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1136\/annrheumdis-2016-210770","article-title":"2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis","volume":"76","author":"van der Heijde","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2022080318254523000_keab901-B32","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s13075-016-1066-2","article-title":"The prevalence and clinical characteristics of nonradiographic axial spondyloarthritis among patients with inflammatory back pain in rheumatology practices: a multinational, multicenter study","volume":"18","author":"Burgos-Vargas","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"2022080318254523000_keab901-B33","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/acr.23017","article-title":"Diagnostic value and validity of early spondyloarthritis features: results from a national Spanish cohort","volume":"69","author":"Joven","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keab901\/41935883\/keab901.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/8\/3299\/45227034\/keab901.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/8\/3299\/45227034\/keab901.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T18:26:48Z","timestamp":1659551208000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/61\/8\/3299\/6460352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,13]]},"references-count":33,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,12,13]]},"published-print":{"date-parts":[[2022,8,3]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keab901","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,8,1]]},"published":{"date-parts":[[2021,12,13]]}}}